EX-99.(C)(2) 2 ny20005154x1_exc2.htm EXHIBIT (C)(2)

Exhibit (c)(2)

 Project Riverlands  Counteroffer Overview 
 

 Counteroffer Overview  1  Today's Close  5-Day  30-Day  Undisturbed Price (1)  30-Day VWAP to  (7/19/2022)  VWAP  VWAP  6/23/2022  Initial Offer Price (2)  PBF Share Price  $28.29  $27.24  $33.59  $30.81  $35.42  PBFX Unit Price  $16.32  $16.32  $15.49  $13.35  $15.64  Exchange Ratio  0.5769x  0.5989x  0.4611x  0.4333x  0.4416x  Cash  $7.82  $7.82  $7.82  $7.82  $7.82  Exchange Ratio  0.2210x  0.2210x  0.2210x  0.2210x  0.2210x  PBF Shares ($)  $6.25  $6.02  $7.42  $6.81  $7.83  Total Offer  $14.07  $13.84  $15.24  $14.63  $15.65  Total Cash Consideration ($ in mm)  $256.3  $256.3  $256.3  $256.3  $256.3  Total Share Consideration ($ in mm)  $204.9  $197.3  $243.4  $223.2  $256.6  Total Shares Issued (mm)  7.2  7.2  7.2  7.2  7.2  Premium / (Discount) to Current  (13.8%)  (15.2%)  (6.6%)  (10.4%)  (4.1%)  Premium / (Discount) to Undisturbed  (11.3%)  (12.7%)  (3.9%)  (7.8%)  (1.3%)  Premium / (Discount) to 52-Week High  (19.6%)  (21.0%)  (12.9%)  (16.5%)  (10.6%)  Implied Exchange Ratio  0.4974x  0.5081x  0.4538x  0.4748x  0.4418x  Cash  $9.25  $9.25  $9.25  $9.25  $9.25  Exchange Ratio  0.2700x  0.2700x  0.2700x  0.2700x  0.2700x  PBF Shares ($)  $7.64  $7.36  $9.07  $8.32  $9.56  Total Offer  $16.89  $16.61  $18.32  $17.57  $18.81  Total Cash Consideration ($ in mm)  $303.2  $303.2  $303.2  $303.2  $303.2  Total Share Consideration ($ in mm)  $250.4  $241.1  $297.3  $272.7  $313.5  Total Shares Issued (mm)  8.9  8.9  8.9  8.9  8.9  Premium / (Discount) to Current  3.5%  1.7%  12.3%  7.7%  15.3%  Premium / (Discount) to Undisturbed  6.5%  4.7%  15.5%  10.8%  18.6%  Premium / (Discount) to 52-Week High  (3.6%)  (5.2%)  4.6%  0.3%  7.4%  Implied Exchange Ratio  0.5970x  0.6095x  0.5454x  0.5702x  0.5312x  Source: Factset as of 7/19/2022.  Note: VWAPs calculated based on trading days.  Counteroffer Analysis  1.  2.  Reflects closing price the day prior to latest 13-D filing. Per initial offer sent 6/28/2022.  Counteroffer Detail  Initial Offer  Counteroffer  On July 19, 2022, the Conflicts Committee of PBF Logistic GP LLC responded to the initial proposal submitted on June 28, 2022 with a counteroffer consisting of:  $9.25 in cash; and  0.2700 PBF shares for each issued and outstanding public unit of PBFX  The proposed counteroffer implies a total per share consideration of $16.89, representing a 3.5% premium to current PBFX unit price as of 7/19/2022 and an implied exchange ratio of 0.5970x  Counteroffer delivered telephonically to Barclays by Intrepid 
 

 Disclaimer  This document has been prepared by Barclays Capital Inc. (“Barclays”) for information purposes only. This document is confidential and is for the intended recipient and cannot be redistributed, published, reproduced or disclosed, in whole or in part, without the prior written permission from Barclays. Moreover, any information provided herein was not prepared for or intended for use by any individual for personal, family or household purposes. This document is an indicative summary of the terms and conditions of the securities/corporate transaction described herein and may be amended, superseded or replaced by subsequent summaries and is not intended to be used for any personal, family or household purpose. The final terms and conditions and any applicable risk factors of the securities/corporate transaction will be set out in full in the applicable offering document(s) or binding transaction document(s).  This material has not been produced by the Barclays Group’s research department and does not constitute investment research or a research recommendation for the purposes of Financial Conduct Authority rules or a research report under U.S. law. The Barclays Group’s research analysts and research departments are independent from Barclays’ banking business and are subject to certain regulations and internal policies. The Barclays Group’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to any company referred to herein, the transactions contemplated herein or any person involved therein or related thereto that differ from or are inconsistent with the views or advice communicated by Barclays’ banking business.  Prices shown in this document are indicative only and Barclays is not offering to buy or sell, or soliciting offers to buy or sell any financial instrument nor is Barclays providing investment advice relating to such financial instrument or making a recommendation to buy or sell any financial instrument. Unless otherwise specified, the source for all graphs, charts, and other information is Barclays. Barclays’ databases are derived from various internal and external sources. Barclays makes no warranty or representation, express or implied, as to the accuracy or completeness of information which is contained in this document and which is stated to have been obtained from or is based upon trade and statistical services or other third party sources. Any data on past performance, modelling, scenario analysis or back-testing contained herein is no indication as to future performance. No representation is made as to the reasonableness of the assumptions made within or the accuracy or completeness of any modelling, scenario analysis or back-testing or any other information contained herein. All levels, prices and spreads are historical and do not represent current market levels, prices or spreads, some or all of which may have changed since the issuance of this document. All opinions and estimates are given as of the date hereof and are subject to change, and Barclays assumes no obligation to update this document to reflect any such changes. The value of any investment may also fluctuate as a result of market changes. The information herein is not intended to predict actual results and no assurances are given with respect thereto.  The recipient is responsible for making its own independent investigation and appraisal of the risks, benefits, appropriateness and suitability of any corporate transaction or commercial or business matter contemplated by this document. Barclays is not making any recommendation (personal, family, household or otherwise) or giving any investment advice. The decision to proceed with any corporate transaction or commercial or business action contemplated by this document must be made by the recipient in light of its own commercial assessments, and Barclays will not be responsible for such assessments. Barclays is not responsible for providing or arranging for the provision of any general financial, strategic or specialist advice, including legal, regulatory, accounting, model auditing or taxation advice or services or any other services in relation to the corporate transaction and/or any related securities described herein.  Neither Barclays nor any of its subsidiaries or affiliates, nor any of their respective officers, directors, employees, agents, advisors or other representatives (Barclays together with such persons being the “Barclays Group”) accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this document or its contents or any reliance on the information contained herein. Barclays Group is not responsible for any specialist advice, including legal, regulatory, accounting, model accounting, tax, actuarial or other advice.  This document does not constitute nor does it form part of an offer to sell or purchase, or the solicitation of an offer to sell or purchase, any securities or any of the businesses or assets described herein or an offer or recommendation to enter into any business or commercial transaction described herein nor does this document constitute an offer or commitment to provide, arrange or underwrite any financing.  Members of Barclays Group are involved in a wide range of commercial banking, investment banking and other activities out of which conflicting interests or duties may arise. Barclays Group may make a market or deal as principal in the securities mentioned in this document or in options or other derivatives based thereon. Barclays Group may be on the opposite side of any orders executed for securities or financial instruments that are related to or the subject of this document. In addition, Barclays Group may also, from time to time, effect transactions for its own account or the account of its clients and hold long or short positions in debt, equity or other securities of the companies referred to herein or in other financial products and instruments. Unless otherwise expressly agreed or provided for in other applicable Barclays disclosures governing such transactions or required by law or regulation, Barclays conducts these activities as principal and executes its principal transactions as an arm’s length counterparty. Barclays does not act as a fiduciary in relation to these transactions. Barclays Group operates in accordance with a conflicts of interest policy that identifies conflicts of interest Barclays Group faces in the ordinary course of its business, and establishes organizational and procedural measures to manage those conflicts where it is reasonably able to do so. Neither Barclays nor any other part of Barclays Group shall have any duty to disclose or utilize for the recipient’s benefit any non-public information acquired in the course of providing services to any other person, engaging in any transaction (on its own account or otherwise) or otherwise carrying on its business. Members of Barclays Group, may from time to time act as manager, co-manager, arranger or underwriter of an offering or otherwise, in the capacity of principal or agent, transact in, hold or act as market-maker or advisor, broker or commercial and/or investment banker in relation to the securities, instruments or related derivatives which are the subject of this document.  NO ACTION HAS BEEN MADE OR WILL BE TAKEN THAT WOULD PERMIT A PUBLIC OFFERING OF THE SECURITIES DESCRIBED HEREIN IN ANY JURISDICTION IN WHICH ACTION FOR THAT PURPOSE IS REQUIRED. NO OFFERS, SALES, RESALES OR DELIVERY OF THE SECURITIES DESCRIBED HEREIN OR DISTRIBUTION OF ANY OFFERING MATERIAL RELATING TO SUCH SECURITIES MAY BE MADE IN OR FROM ANY JURISDICTION EXCEPT IN CIRCUMSTANCES WHICH WILL RESULT IN COMPLIANCE WITH ANY APPLICABLE LAWS AND REGULATIONS AND WHICH WILL NOT IMPOSE ANY OBLIGATION ON BARCLAYS OR ANY OF ITS AFFILIATES.  THIS DOCUMENT DOES NOT DISCLOSE ALL THE RISKS AND OTHER SIGNIFICANT ISSUES RELATED TO AN INVESTMENT IN THE SECURITIES DESCRIBED HEREIN. PRIOR TO TRANSACTING, POTENTIAL INVESTORS SHOULD ENSURE THAT THEY FULLY UNDERSTAND THE TERMS OF THE RELEVANT SECURITIES AND ANY APPLICABLE RISKS.  THE INFORMATION CONTAINED HEREIN IS NOT INTENDED TO BE DISTRIBUTED TO ANY PROSPECTIVE OR ACTUAL INVESTORS AND, ACCORDINGLY, MAY NOT BE SHOWN OR GIVEN TO ANY PERSON OTHER THAN THE RECIPIENT, AND IS NOT TO BE FORWARDED TO ANY OTHER PERSON (INCLUDING ANY RETAIL INVESTOR OR CUSTOMER), COPIED OR OTHERWISE REPRODUCED OR DISTRIBUTED TO ANY SUCH PERSON IN ANY MANNER WHATSOEVER. FAILURE TO COMPLY WITH THIS DIRECTIVE CAN RESULT IN A VIOLATION OF THE SECURITIES ACT OF 1933, AS AMENDED.  Barclays Capital Inc. is the United States investment bank of Barclays Bank PLC. Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority (Financial Services Register No. 122702). Registered in England. Registered No. 1026167. Registered office: 1 Churchill Place, London E14 5HP. Copyright Barclays Bank PLC, 2022 (all rights reserved).  2